X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/rhovac-board-member-resigns-due-to-health-reasons-301652079.html
https://www.clinicaltrialsarena.com/news/rhovac-prostate-cancer-trial/
https://www.prnewswire.com/news-releases/rhovac-ab-announces-database-lock-in-its-clinical-phase-iib-trial-of-onilcamotide-301544454.html
https://www.prnewswire.com/news-releases/another-clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301440945.html
https://www.prnewswire.com/news-releases/rhovac-presents-3-year-follow-up-results-of-the-phase-iii-study-in-prostate-cancer-301392659.html
https://www.prnewswire.com/news-releases/clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301328656.html
https://www.prnewswire.com/news-releases/mount-sinai-hospital-in-new-york-joins-rhovacs-phase-iib-study-in-prostate-cancer-301273850.html
https://www.prnewswire.com/news-releases/global-covid-19-vaccination-roll-out-causes-delay-to-rhovacs-phase-iib-study-301242561.html
https://www.prnewswire.com/news-releases/first-patient-in-treatment-in-rhovacs-clinical-phase-iib-study-in-united-kingdom-301202827.html
https://www.prnewswire.com/news-releases/positive-results-from-rhovacs-clinical-phase-iii-study-published-in-journal-of-immunotherapy-of-cancer-301172624.html
Market Place
Share 
